Stayble Therapeutics AB (publ) (STO:STABL)
Sweden
· Delayed Price · Currency is SEK 0.170
-0.004 (-2.07%)
Mar 9, 2026, 12:34 PM CET
Stayble Therapeutics AB Revenue
In the year 2025, Stayble Therapeutics AB had annual revenue of 47.00K SEK. Stayble Therapeutics AB had revenue of 1,000.00 in the quarter ending December 31, 2025.
Revenue
47.00K
Revenue Growth
n/a
P/S Ratio
237.72
Revenue / Employee
23.50K
Employees
2
Market Cap
11.17M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NanoEcho AB | 487.00K |
| Fluicell AB | 15.22M |
| Novakand Pharma AB | 14.00K |
| Aptahem AB | 2.59M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Lipigon Pharmaceuticals AB | 1.32M |
| Nanologica AB | 21.13M |
| 2cureX AB | 1.98M |